Which anaesthetic agents and techniques are most cost-effective in day surgery?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN87609400

Enrollment

1760

Registered

2003-04-25

Start date

1999-03-01

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable Not Applicable

Interventions

The adult study has four arms (propofol then propofol

propofol then isoflurane/N2O propofol then sevoflurane then sevoflurane/N2O), 330 patients in each arm. The paediatric study has two arms (thiopentone [ages 3 to 6] or propofol [ages 7 to 10] then hal

sevoflurane then hevoflurane/N2O [ages 3 to 10]), 220 patients in each arm.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult general, orthopaedic and gynaecology patients, and paediatric general and ear, nose and throat (ENT) patients.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Postoperative nausea and vomiting (PONV)	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

Scotland, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026